A61K 9/0082
Lung surfactant, artificial mucus
Official title: {Lung surfactant, artificial mucus}
A61K9/0082 (Lung surfactant, artificial mucus) appears on 62 US grants and 89 published applications in this corpus.
Search patents in A61K- Granted patents
- 62
- Published applications
- 89
- Assignees
- 58
- Inventors
- 181
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 2 |
| 2003 | 1 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 2 | 3 |
| 2007 | 0 | 4 |
| 2008 | 1 | 6 |
| 2009 | 2 | 1 |
| 2010 | 0 | 3 |
| 2011 | 2 | 3 |
| 2012 | 4 | 4 |
| 2013 | 4 | 5 |
| 2014 | 5 | 6 |
| 2015 | 1 | 3 |
| 2016 | 4 | 4 |
| 2017 | 3 | 1 |
| 2018 | 3 | 4 |
| 2019 | 2 | 3 |
| 2020 | 2 | 3 |
| 2021 | 1 | 12 |
| 2022 | 2 | 5 |
| 2023 | 1 | 5 |
| 2024 | 0 | 6 |
| 2025 | 3 | 2 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of BPD5 May 2026US 12,616,741 B2Children's Hospital Medical Center
- Solution and method for reducing the virulence of viruses, bacteria, yeasts, or fungus28 Apr 2026US 12,611,380 B2
- Mesenchymal stem cell-derived extracellular vesicles and uses thereof for treating and diagnosing fibrotic diseases31 Mar 2026US 12,589,117 B2Exopharma, Inc.
- Compositions, methods, and applications of a synthetic surfactant16 Dec 2025US 12,495,796 B21283581 Bc Ltd
- Polymer lung surfactants21 Oct 2025US 12,447,175 B2Purdue Research Foundation
- Methods for Treating Premature Newborn Infants by Administration of Recombinant Human Surfactant Protein D (rhSP-D)20 Aug 2026US 2026/0240946 A1Airway Therapeutics, Inc.
- Surfactant Formulations for Inhalation18 Sep 2025US 2025/0288516 A1Merz Pharmaceuticals, LLC
- Surfactant Formulations for Inhalation21 Aug 2025US 2025/0262150 A1Merz Pharmaceuticals, LLC
- Silk fibroin-containing composition and methods of use thereof12 Dec 2024US 2024/0408173 A1Georgetown University
- Process for the preparation of a pulmonary surfactant7 Nov 2024US 2024/0366682 A1Chiesi Farmaceutici S.P. A.
Most cited
By later US patents
- Pulmonary administration of pharmaceutically active substances238US 5,006,343 A1991
- Pulmonary drug delivery system160US 5,451,569 AHong Kong University of Science and Technology R & D Corporation Limited · 1995
- Use of surface active agents to promote mucus clearance59US 5,925,334 A1999
- Method of administering phospholipid dispersions44US 5,299,566 ABurroughs Wellcome Co. · 1994
- Use of simple amino acids to form porous particles during spray drying41US 6,586,008 B1Advanced Inhalation Research, Inc. · 2003